Clinical trials are required to prove the ch... [Arch Intern Med. 2006] - PubMed

loading

Lipophilic statins merit additional study for breast cancer chemoprevention. [J Clin Oncol. 2006]
Lipophilic statins merit additional study for breast cancer chemoprevention.
Prowell TM, Stearns V, Trock B. J Clin Oncol. 2006 May 1; 24(13):2128-9; author reply 2129.
Review Statins and the colorectum: hope for chemoprevention? [Cancer Prev Res (Phila). 2010]
Review Statins and the colorectum: hope for chemoprevention?
Baron JA. Cancer Prev Res (Phila). 2010 May; 3(5):573-5. Epub 2010 Apr 19.
A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. [J Clin Oncol. 2006]
A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.
Kumar AS, Campbell M, Benz CC, Esserman LJ. J Clin Oncol. 2006 May 1; 24(13):2127; author reply 2127-8.
Statins and breast cancer prevention: time for randomized controlled trials. [J Clin Oncol. 2006]
Statins and breast cancer prevention: time for randomized controlled trials.
Sprague JR, Wood ME. J Clin Oncol. 2006 May 1; 24(13):2129-30; author reply 2130-1.
Review Chemoprevention of breast cancer. [Expert Rev Anticancer Ther. 2008]
Review Chemoprevention of breast cancer.
Castrellon AB, Glück S. Expert Rev Anticancer Ther. 2008 Mar; 8(3):443-52.

Clinical trials are required to prove the chemopreventive worth of statins.
Clinical trials are required to prove the chemopreventive worth of statins.
Arch Intern Med. 2006 May 22 ;166(10):1143; author reply 1144.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed